skip to Global Navigation Bar skip to main content


homeHome > Press Release > News

News

News Content
Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota
Date 2016-09-22 Hit 6700
list
News List
Prev Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS
Next Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension